PTC Therapeutics Inc at Credit Suisse Healthcare Conference (Virtual) Transcript
© -
Okay. Hey, everybody. I am Marty Auster. I'm the lead SMID cap biotech analyst at Crédit Suisse. Welcome to the 29th Annual Crédit Suisse Healthcare Conference, First Virtual Conference. I'm happy to have PTC Therapeutics today.
I've got Stu Peltz, CEO of the company, along with several members of the team. Stu, I was just about to say in the breakout. I was -- I had every best intention to kind of do this in front of a fireplace, and it's been like 70-plus degrees all week in Vermont and apparently warmer than in Phoenix. So I don't know what to say, but maybe next year, we'll actually get a fire.
But let me hand it over to you to introduce who's all joining you today from the team. And maybe if you could also just make an intro kind of an overview comment about kind of the PTC vision.
Sure. Thanks for having us. Sort of nice to be in warm Vermont, I
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |